Mercury Laboratories [MERCURYLAB] vs Sequent Scientific [SEQUENT] Detailed Stock Comparison
Mercury Laboratories
BSE
Loading...
Sequent Scientific
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Mercury Laboratories wins in 15 metrics, Sequent Scientific wins in 3 metrics, with 0 ties. Mercury Laboratories appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Mercury Laboratories | Sequent Scientific | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 31.75 | 154.18 | Mercury Laboratories |
| Price-to-Book Ratio | 1.86 | 6.24 | Mercury Laboratories |
| Debt-to-Equity Ratio | 10.18 | 62.47 | Mercury Laboratories |
| PEG Ratio | N/A | 1.29 | N/A |
| EV/EBITDA | 14.09 | 29.36 | Mercury Laboratories |
| Profit Margin (TTM) | 4.93% | 1.85% | Mercury Laboratories |
| Operating Margin (TTM) | 8.34% | 7.56% | Mercury Laboratories |
| EBITDA Margin (TTM) | 8.34% | 7.56% | Mercury Laboratories |
| Return on Equity | 5.87% | 2.84% | Mercury Laboratories |
| Return on Assets (TTM) | 4.24% | 1.37% | Mercury Laboratories |
| Free Cash Flow (TTM) | $-50.39M | $442.73M | Sequent Scientific |
| Dividend Yield | 0.82% | N/A | N/A |
| 1-Year Return | -11.21% | 22.66% | Sequent Scientific |
| Price-to-Sales Ratio (TTM) | 1.30 | 2.74 | Mercury Laboratories |
| Enterprise Value | $1.04B | $48.76B | Sequent Scientific |
| EV/Revenue Ratio | 1.36 | 3.04 | Mercury Laboratories |
| Gross Profit Margin (TTM) | 61.02% | 46.86% | Mercury Laboratories |
| Revenue per Share (TTM) | $638 | $64 | Mercury Laboratories |
| Earnings per Share (Diluted) | $26.21 | $1.14 | Mercury Laboratories |
| Beta (Stock Volatility) | 0.63 | 0.91 | Mercury Laboratories |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Mercury Laboratories vs Sequent Scientific Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Mercury Laboratories | 3.36% | -5.06% | -3.51% | -1.71% | -2.00% | -6.52% |
| Sequent Scientific | -0.07% | 0.45% | -5.27% | 0.82% | 19.96% | -4.81% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Mercury Laboratories | -11.21% | 78.94% | 85.83% | 264.61% | 2,224.16% | 2,224.16% |
| Sequent Scientific | 22.66% | 59.79% | 34.23% | 19.22% | 19.22% | 19.22% |
Performance & Financial Health Analysis: Mercury Laboratories vs Sequent Scientific
| Metric | MERCURYLAB | SEQUENT |
|---|---|---|
| Market Information | ||
| Market Cap | ₹998.46M | ₹43.92B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 92 | 740,868 |
| 90 Day Avg. Volume | 174 | 544,283 |
| Last Close | ₹860.00 | ₹175.64 |
| 52 Week Range | ₹736.00 - ₹1,190.00 | ₹117.35 - ₹240.70 |
| % from 52W High | -27.73% | -27.03% |
| All-Time High | ₹1,303.00 (Jan 08, 2024) | ₹336.50 (Jun 28, 2021) |
| % from All-Time High | -34.00% | -47.80% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.09% | 0.13% |
| Quarterly Earnings Growth | 1.83% | 1.20% |
| Financial Health | ||
| Profit Margin (TTM) | 0.05% | 0.02% |
| Operating Margin (TTM) | 0.08% | 0.08% |
| Return on Equity (TTM) | 0.06% | 0.03% |
| Debt to Equity (MRQ) | 10.18 | 62.47 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹446.41 | ₹28.19 |
| Cash per Share (MRQ) | ₹12.97 | ₹2.52 |
| Operating Cash Flow (TTM) | ₹-12,625,000 | ₹360.47M |
| Levered Free Cash Flow (TTM) | ₹31.45M | ₹218.78M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.82% | N/A |
| Last 12-Month Dividend | ₹7.00 | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Mercury Laboratories vs Sequent Scientific
| Metric | MERCURYLAB | SEQUENT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 31.75 | 154.18 |
| Forward P/E | N/A | 34.81 |
| PEG Ratio | N/A | 1.29 |
| Price to Sales (TTM) | 1.30 | 2.74 |
| Price to Book (MRQ) | 1.86 | 6.24 |
| Market Capitalization | ||
| Market Capitalization | ₹998.46M | ₹43.92B |
| Enterprise Value | ₹1.04B | ₹48.76B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.36 | 3.04 |
| Enterprise to EBITDA | 14.09 | 29.36 |
| Risk & Other Metrics | ||
| Beta | 0.63 | 0.91 |
| Book Value per Share (MRQ) | ₹446.41 | ₹28.19 |
Financial Statements Comparison: Mercury Laboratories vs Sequent Scientific
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MERCURYLAB | SEQUENT |
|---|---|---|
| Revenue/Sales | ₹206.59M | ₹4.41B |
| Cost of Goods Sold | ₹80.52M | ₹2.35B |
| Gross Profit | ₹126.07M | ₹2.07B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹13.94M | ₹333.50M |
| EBITDA | ₹23.07M | ₹505.30M |
| Pre-Tax Income | ₹14.47M | ₹255.20M |
| Income Tax | ₹3.37M | ₹79.50M |
| Net Income (Profit) | ₹11.10M | ₹175.70M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MERCURYLAB | SEQUENT |
|---|---|---|
| Cash & Equivalents | ₹3.32M | ₹626.60M |
| Total Current Assets | ₹400.80M | ₹8.74B |
| Total Current Liabilities | ₹150.76M | ₹5.05B |
| Long-Term Debt | ₹37.83M | ₹3.00B |
| Total Shareholders Equity | ₹535.69M | ₹7.70B |
| Retained Earnings | N/A | ₹1.25B |
| Property, Plant & Equipment | ₹246.15M | ₹2.84B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MERCURYLAB | SEQUENT |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | MERCURYLAB | SEQUENT |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 92 | 740,868 |
| Average Daily Volume (90 Day) | 174 | 544,283 |
| Shares Outstanding | 1.20M | 249.89M |
| Float Shares | 166,416 | 117.77M |
| % Held by Insiders | 0.86% | 0.53% |
| % Held by Institutions | 0.00% | 0.13% |
Dividend Analysis & Yield Comparison: Mercury Laboratories vs Sequent Scientific
| Metric | MERCURYLAB | SEQUENT |
|---|---|---|
| Last 12-Month Dividend | ₹7.00 | ₹0.00 |
| Last 12-Month Dividend Yield | 0.82% | N/A |
| 3-Year Avg Annual Dividend | ₹4.67 | ₹0.00 |
| 3-Year Avg Dividend Yield | 0.43% | N/A |
| 3-Year Total Dividends | ₹14.00 | ₹0.00 |
| Ex-Dividend Date | Aug 06, 2025 | N/A |